BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11025472)

  • 1. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood.
    van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
    Med Pediatr Oncol; 2000 Oct; 35(4):415-20. PubMed ID: 11025472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
    van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
    Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral assessment with tibial ultrasonometry and dual-energy X-ray absorptiometry in long-term survivors of acute lymphoblastic leukemia in childhood.
    Lequin MH; van der Shuis IM; Van Rijn RR; Hop WC; van ven Huevel-Eibrink MM; MuinckKeizer-Schrama SM; van Kuijk C
    J Clin Densitom; 2002; 5(2):167-73. PubMed ID: 12110760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
    Lem AJ; van der Kaay DC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia.
    Tillmann V; Darlington AS; Eiser C; Bishop NJ; Davies HA
    J Bone Miner Res; 2002 Jun; 17(6):1073-80. PubMed ID: 12054163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health.
    Bloomhardt HM; Sint K; Ross WL; Rotatori J; Ness K; Robinson C; Carpenter TO; Chow EJ; Kadan-Lottick NS
    Cancer; 2020 Jan; 126(1):202-210. PubMed ID: 31536650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia.
    Hoorweg-Nijman JJ; Kardos G; Roos JC; van Dijk HJ; Netelenbos C; Popp-Snijders C; de Ridder CM; Delemarre-van de Waal HA
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):237-44. PubMed ID: 10396368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.
    van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
    J Pediatr; 2002 Aug; 141(2):204-10. PubMed ID: 12183715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only.
    van Beek RD; van den Heuvel-Eibrink MM; Hakvoort-Cammel FG; van den Bos C; van der Pal HJ; Krenning EP; de Rijke YB; Pieters R; de Muinck Keizer-Schrama SM
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1904-9. PubMed ID: 19293271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships of Bone Mineral Density to Whole Body Mass, Fat Mass and Fat-free Mass in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood.
    Athale UH; Marriott CJC; Cranston A; McDonald P; Webber CE; Farncombe TH; Barr RD
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):12-17. PubMed ID: 32675554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Mineral Density Corrected for Size in Childhood Leukaemia Survivors Treated with Haematopoietic Stem Cell Transplantation and Total Body Irradiation.
    Wei C; Candler T; Davis N; Elson R; Crabtree N; Stevens M; Crowne E
    Horm Res Paediatr; 2018; 89(4):246-254. PubMed ID: 29804121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up study.
    van der Sluis IM; Boot AM; Hop WC; De Rijke YB; Krenning EP; de Muinck Keizer-Schrama SM
    Horm Res; 2002; 58(5):207-14. PubMed ID: 12401939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic susceptibility and late bone outcomes in childhood acute lymphoblastic leukemia survivors.
    Geneviève N; Mojgan Y; Nahid Y; Vincenzo F; Simon G; Daniel S; Maja K; Nathalie A; Despoina M
    J Bone Miner Res; 2024 Mar; 39(2):130-138. PubMed ID: 38477791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
    Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
    Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Little evidence of low bone mass in acute lymphoblastic leukemia survivors.
    Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J
    J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mass after treatment for acute lymphoblastic leukemia in childhood.
    Nysom K; Holm K; Michaelsen KF; Hertz H; Müller J; Mølgaard C
    J Clin Oncol; 1998 Dec; 16(12):3752-60. PubMed ID: 9850018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.